Talis Biomedical (TLIS)
US Market

Talis Biomedical (TLIS) Stock Price & Analysis


TLIS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.42 - $1.20
Previous Close$0.49
Average Volume (3M)115.59K
Market Cap
Enterprise Value-$71.45M
Total Cash (Recent Filing)$113.97M
Total Debt (Recent Filing)$14.71M
Price to Earnings (P/E)-0.1
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.66
Shares Outstanding53,343,550
10 Day Avg. Volume247,002
30 Day Avg. Volume115,595
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-47.99
Enterprise Value/Gross Profit8.52
Enterprise Value/Ebitda0.79
Price Target Upside-28.63% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Talis Biomedical’s price range in the past 12 months?
Talis Biomedical lowest stock price was $0.42 and its highest was $1.20 in the past 12 months.
    What is Talis Biomedical’s market cap?
    Currently, no data Available
    When is Talis Biomedical’s upcoming earnings report date?
    Talis Biomedical’s upcoming earnings report date is Aug 08, 2023 which is in 68 days.
      How were Talis Biomedical’s earnings last quarter?
      Talis Biomedical released its earnings results on May 11, 2023. The company reported -$0.66 earnings per share for the quarter, beating the consensus estimate of -$0.692 by $0.032.
        Is Talis Biomedical overvalued?
        According to Wall Street analysts Talis Biomedical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Talis Biomedical pay dividends?
          Talis Biomedical does not currently pay dividends.
          What is Talis Biomedical’s EPS estimate?
          Talis Biomedical’s EPS estimate is -$0.64.
            How many shares outstanding does Talis Biomedical have?
            Talis Biomedical has 26,879,820 shares outstanding.
              What happened to Talis Biomedical’s price movement after its last earnings report?
              Talis Biomedical reported an EPS of -$0.66 in its last earnings report, beating expectations of -$0.692. Following the earnings report the stock price went down -11.538%.
                Which hedge fund is a major shareholder of Talis Biomedical?
                Among the largest hedge funds holding Talis Biomedical’s share is Baker Bros Advisors LP. It holds Talis Biomedical’s shares valued at 4M.


                  Talis Biomedical Stock Smart Score

                  Not Ranked
                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Talis Biomedical

                  Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.


                  Top 5 ETFs holding TLIS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold TLIS. The ETFs are listed according to market value of TLIS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  TransMedics Group
                  Intellia Therapeutics
                  Arcturus Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis